PetMed Express (NASDAQ:PETS) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of PetMed Express (NASDAQ:PETS) from a hold rating to a sell rating in a research report report published on Saturday.

Several other equities analysts also recently weighed in on PETS. Weiss Ratings upgraded shares of PetMed Express from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Zacks Research upgraded shares of PetMed Express to a “hold” rating in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce”.

PetMed Express Stock Performance

PetMed Express stock opened at $1.75 on Friday. The business’s 50-day simple moving average is $1.91 and its two-hundred day simple moving average is $2.28. The company has a market cap of $37.40 million, a PE ratio of -1.27 and a beta of 0.76. PetMed Express has a fifty-two week low of $1.57 and a fifty-two week high of $4.10.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.40). PetMed Express had a negative net margin of 17.34% and a negative return on equity of 91.69%. The firm had revenue of $41.02 million during the quarter, compared to analyst estimates of $71.00 million. As a group, analysts predict that PetMed Express will post 0.07 EPS for the current fiscal year.

Institutional Trading of PetMed Express

A number of hedge funds have recently modified their holdings of PETS. BlackRock Inc. acquired a new stake in PetMed Express during the second quarter worth about $1,091,000. Empowered Funds LLC lifted its holdings in PetMed Express by 9.3% in the first quarter. Empowered Funds LLC now owns 75,024 shares of the company’s stock valued at $171,000 after acquiring an additional 6,373 shares during the period. Rangeley Capital LLC lifted its holdings in PetMed Express by 45.6% in the first quarter. Rangeley Capital LLC now owns 109,208 shares of the company’s stock valued at $249,000 after acquiring an additional 34,208 shares during the period. Sei Investments Co. boosted its position in PetMed Express by 42.0% in the 1st quarter. Sei Investments Co. now owns 23,000 shares of the company’s stock worth $52,000 after purchasing an additional 6,800 shares in the last quarter. Finally, Formidable Asset Management LLC boosted its position in PetMed Express by 13.0% in the 1st quarter. Formidable Asset Management LLC now owns 105,201 shares of the company’s stock worth $240,000 after purchasing an additional 12,141 shares in the last quarter. Hedge funds and other institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.